Priveq investment has as of today closed the exit transaction made on November 5th, 2009, thus sealing the outcome of the most successful exit, money multiple-wise, of our 27 years of history. The transaction was conditioned by a positive outcome in the Biovitrum EGM as of December 4th 2009.
Thereby concluding a >26x-investment, excluding a possible additional 3x dependant on further company performance, with an IRR exceeding 80 per cent we are happy to contribute to the initiation of a new, strong, Swedish specialist pharmaceutical company in the listed Swedish Orphan Biovitrum AB.
For more information, please contact us at +46 8 459 67 60.
[hr top=”20″ bottom=”20″]
[register_getpdf pdftitle=”Press release” pdflink=”https://www.priveq.se/wp-content/uploads/2016/01/Priveq-closes-most-successful-exit-ever.pdf”]
[hr top=”20″ bottom=”20″]